PER 1.18% 8.4¢ percheron therapeutics limited

And you seem to have no idea the risks and expense of getting a...

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    And you seem to have no idea the risks and expense of getting a drug to market, let alone making a profit.

    Sarepta have 3 drugs commercially making US$ one billion in annual revenue and they still lose $500 mill a year.

    They spent US$440 mill in R&D costs on SRP-9001 last year and it hasn’t made a dollar in revenue yet.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.4¢
Change
-0.001(1.18%)
Mkt cap ! $75.72M
Open High Low Value Volume
8.4¢ 8.4¢ 8.3¢ $3.097K 37.23K

Buyers (Bids)

No. Vol. Price($)
1 29206 8.3¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 118557 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.